News

Expert explains cardiac amyloidosis

Expert explains cardiac amyloidosis

Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the body, including the heart, liver and kidneys. When amyloids form in the heart, the condition is referred to as cardiac amyloidosis…

Will Psychedelics Break the Major Depression Logjam?

With tens of millions of euros in the offing, researchers across the European Union have eagerly taken up the gauntlet to find novel interventions for difficult-to-treat mental health and pain conditions. Their target is psychedelics, including classic compounds like psilocybin and atypical ones like ketamine and MDMA…

Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

Varying dialysate calcium dosage not tied to differences in all-cause, cardiovascular mortality

There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing hemodialysis, according to a study published online Oct. 4 in the Clinical Kidney Journal. Karlien J. ter Meulen, from Maastricht University Medical Centre in the Netherlands, and colleagues investigated the association between

Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

Trial analysis shows vitamin D supplementation doesn’t cut cardiac risk

Graphical abstract Geometric means (95 % confidence intervals) of (A) high-sensitivity cardiac troponin I (hs-cTnI, ng/L), a marker of cardiac injury, and (B) N-terminal pro-b-type natriuretic peptide (NT-proBNP, pg/mL), a marker of cardiac strain, according to vitamin D3 supplementation assignment at baseline (Bl) and after 3-month, 12-month, and 24-month periods. Credit: American Journal of Preventive